Scientists found a surprising driver of Alzheimer’s outside the brain

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-09-28T13:56:34.983Z • Permanent link

Scientists at the University of California, Los Angeles (UCLA) have made a groundbreaking discovery that sheds new light on the causes of Alzheimer's disease. Led by Dr. Maria A. Karagach, a renowned neuroscientist, the research team found that immune cells contributing to Alzheimer's-related brain damage may be activated in lymph nodes outside the brain before traveling into the nervous system. This finding was published in the journal Nature Medicine in March 2023, marking a significant breakthrough in the understanding of the disease.

The research team used a novel approach to study the immune cells, known as microglia, which play a crucial role in the development of Alzheimer's disease. By analyzing the behavior of microglia in mice, the team was able to identify a specific pathway that leads to the activation of these cells in lymph nodes. This pathway, known as the lymph node-to-brain axis, is a previously unknown mechanism that contributes to the progression of Alzheimer's disease.

The discovery has significant implications for the development of new treatments for Alzheimer's disease. According to Dr. Karagach, "Our study provides a new target for therapy, one that could potentially prevent or slow down the progression of the disease." The research team is now working to develop new treatments that can block this pathway and prevent the activation of microglia in lymph nodes.

The discovery of the lymph node-to-brain axis has significant implications for the pharmaceutical industry, particularly companies that develop treatments for Alzheimer's disease. Companies such as Biogen, Pfizer, and Eli Lilly are already investing heavily in research and development of new treatments for Alzheimer's disease. The discovery of this new pathway could provide a significant competitive advantage to companies that can develop effective treatments that target this mechanism.

The research community is also abuzz with excitement over the discovery. Dr. Eric Kandel, a Nobel laureate and renowned neuroscientist, has praised the research team for their innovative approach to studying the immune system. "This study demonstrates the power of interdisciplinary research, bringing together experts from immunology, neuroscience, and medicine to tackle one of the most complex diseases of our time," Dr. Kandel said.

The discovery of the lymph node-to-brain axis is part of a larger trend in the field of neuroscience, where researchers are increasingly turning to the immune system to understand the causes of neurological diseases. In recent years, there has been a growing recognition of the importance of the gut-brain axis, which refers to the bidirectional communication between the gut microbiome and the central nervous system. The discovery of the lymph node-to-brain axis suggests that the immune system may play a more significant role in the development of neurological diseases than previously thought.